Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution

Nat Commun. 2020 Jul 9;11(1):3431. doi: 10.1038/s41467-020-17249-7.

Abstract

Claudin-low breast cancers are aggressive tumors defined by the low expression of key components of cellular junctions, associated with mesenchymal and stemness features. Although they are generally considered as the most primitive breast malignancies, their histogenesis remains elusive. Here we show that this molecular subtype of breast cancers exhibits a significant diversity, comprising three main subgroups that emerge from unique evolutionary processes. Genetic, gene methylation and gene expression analyses reveal that two of the subgroups relate, respectively, to luminal breast cancers and basal-like breast cancers through the activation of an EMT process over the course of tumor progression. The third subgroup is closely related to normal human mammary stem cells. This unique subgroup of breast cancers shows a paucity of genomic aberrations and a low frequency of TP53 mutations, supporting the emerging notion that the intrinsic properties of the cell-of-origin constitute a major determinant of the genetic history of tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Carcinogenesis / genetics
  • Carcinogenesis / pathology
  • Cell Differentiation
  • Cell Line, Tumor
  • Claudins / metabolism*
  • DNA Copy Number Variations / genetics
  • DNA Methylation / genetics
  • Epithelial-Mesenchymal Transition / genetics
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genetic Heterogeneity
  • Genome, Human
  • Humans
  • Ploidies
  • Signal Transduction / genetics

Substances

  • Claudins